Ken Toba
Impact in
- Hematology top 2%
- Erythropoietin and Anemia Treatment
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Hematology 38
- Erythropoietin and Anemia Treatment 12
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 7
- Immunology 37
- Immunotherapy and Immune Responses 23
- T-cell and B-cell Immunology 18
- Immune Cell Function and Interaction 16
- Co-authors
- Yoshifusa AizawaTatsuo FurukawaMasuhiro TakahashiHaruo HanawaMiwako NaritaMakoto KodamaIchiro FuseTadashi Koike
- Journals
- Leukemia Research (12 papers)Circulation Journal (6 papers)International Journal of Hematology (5 papers)Medical Oncology (4 papers)Blood (3 papers)
- Partner nations
- JapanAustraliaUnited States
In The Last Decade
Ken Toba
94 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 98
- Hematology 399
- Immunology 593
- Genetics 233
- Oncology 300
- Cardiology and Cardiovascular Medicine 225
Countries citing papers authored by Ken Toba
This map shows the geographic impact of Ken Toba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Toba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Toba more than expected).
Fields of papers citing papers by Ken Toba
This network shows the impact of papers produced by Ken Toba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Toba. The network helps show where Ken Toba may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Toba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 3 | |
| 2 | 2012 | 27 | |
| 3 | A Novel Program to Accurately Quantify Infarction Volume by ^ Tc MIBI SPECT, and Its Application for Re-Analyzing the Effect of Erythropoietin Administration in Patients With Acute Myocardial Infarction : A Randomized Controlled Pilot Trial of the EPO/AMI-I Study | 2010 | 3 |
| 4 | 2010 | 24 | |
| 5 | 2010 | 8 | |
| 6 | 2 Evaluation of the Prospective Observation of Erythropoietin-Administration for the Treatment of Acute Myocardial Infarction (EPO-AMI)(Late Breaking Clinical Trials II,The 73rd Annual Scientific Meeting of The Japanese Circulation Society) | 2009 | 1 |
| 7 | 2007 | 5 | |
| 8 | 2006 | 98 | |
| 9 | 2005 | 3 | |
| 10 | 2004 | 10 | |
| 11 | 2004 | 3 | |
| 12 | 2004 | 4 | |
| 13 | 2003 | 17 | |
| 14 | 2003 | 21 | |
| 15 | 2003 | 4 | |
| 16 | 2002 | 23 | |
| 17 | 2001 | 5 | |
| 18 | 2000 | 41 | |
| 19 | 1999 | 16 | |
| 20 | 1997 | 4 |
About Ken Toba
Ken Toba is a scholar working on Hematology, Immunology, Genetics, Cardiology and Cardiovascular Medicine and Health Informatics, having authored 97 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (23 papers), T-cell and B-cell Immunology (18 papers), Immune Cell Function and Interaction (16 papers), Erythropoietin and Anemia Treatment (12 papers), CAR-T cell therapy research (12 papers), Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (7 papers). The work is most often cited by research in Hematology (399 citations), Immunology (593 citations), Genetics (233 citations), Oncology (300 citations) and Cardiology and Cardiovascular Medicine (225 citations). Ken Toba has collaborated with scholars based in Japan, Australia and United States. Frequent co-authors include Yoshifusa Aizawa, Tatsuo Furukawa, Masuhiro Takahashi, Haruo Hanawa, Miwako Narita, Makoto Kodama, Ichiro Fuse, Tadashi Koike, Kiminori Kato and Kaori Yoshida. Their work appears in journals such as Leukemia Research, Circulation Journal, International Journal of Hematology, Medical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.